Adalat Cc
NDC 67544-185
Product Information
Adalat Cc is a NDA-approved product labeled by Aphena Pharma Solutions - Tennessee, Llc. This medication is used alone or in combination with other drugs to treat high blood pressure (hypertension). It is supplied as a pink product. This product entry covers the primary NDC 67544-185 and 3 associated package configurations. This profile includes active and inactive ingredient UNII references and FDA labeling data.
Primary Identification
Labeler & Regulatory Data
Marketing Timeline
Product Characteristics
90;ADALAT;CC
Code Structure Chart
Product Details
What is NDC 67544-185?
What are the uses of this product?
Which are the associated UNII Codes?
The UNII codes for the active ingredients in this product are:
- NIFEDIPINE (UNII: I9ZF7L6G2L)
- NIFEDIPINE (UNII: I9ZF7L6G2L) (Active Moiety)
Which are the Inactive Ingredients associated UNII Codes?
The inactive ingredients are all the component of a medicinal product OTHER than the active ingredient(s). The acronym "UNII" stands for “Unique Ingredient Identifier” and is used to identify each inactive ingredient present in a product. The UNII codes for the inactive ingredients in this product are:
- CELLULOSE, MICROCRYSTALLINE (UNII: OP1R32D61U)
- CROSPOVIDONE (UNII: 68401960MK)
- FERRIC OXIDE RED (UNII: 1K09F3G675)
- HYDROXYPROPYL CELLULOSE (UNII: RFW2ET671P)
- HYPROMELLOSES (UNII: 3NXW29V3WO)
- LACTOSE (UNII: J2B2A4N98G)
- MAGNESIUM STEARATE (UNII: 70097M6I30)
- POLYETHYLENE GLYCOLS (UNII: 3WJQ0SDW1A)
- SILICON DIOXIDE (UNII: ETJ7Z6XBU4)
- STARCH, CORN (UNII: O8232NY3SJ)
- TITANIUM DIOXIDE (UNII: 15FIX9V2JP)
What is the NDC to RxNorm Crosswalk for this product?
- RxCUI: 198036 - NIFEdipine 90 MG 24HR Extended Release Oral Tablet
- RxCUI: 198036 - 24 HR nifedipine 90 MG Extended Release Oral Tablet
- RxCUI: 198036 - nifedipine 90 MG 24 HR Extended Release Oral Tablet
- RxCUI: 672918 - ADALAT CC 90 MG 24HR Extended Release Oral Tablet
- RxCUI: 672918 - 24 HR nifedipine 90 MG Extended Release Oral Tablet [Adalat]
* Please review the full disclaimer at the bottom of this page.